News | July 15, 2022
Novavax statement on EMA Nuvaxovid label update related to allergic reaction
Novavax’ clinical development program reported no severe allergic reactions
Novavax’ clinical development program reported no severe allergic reactions
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomes
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Plant is part of the company's CAD $30 million capital investment in the site
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
Subscribe To Our Newsletter & Stay Updated
